Industry NewsAstraZeneca Selects Location for New Global R&D Centre and Corporate Headquarters in Cambridge, UK
Industry NewsNew Webinar Announcement - New Methods for Proteomic, Lipidomic & Metabolomic Studies of Infectious Disease and Cancer
Industry NewsBioInvent Extends Collaboration for the Discovery and Development of Therapeutic Antibodies with Mitsubishi Tanabe
Industry NewsAstraZeneca and Sarah Cannon Research Institute Announce Personalized Medicine Partnership and Enhanced Strategic Clinical Development Collaboration